Zika virus (ZIKV) was identified in 1947 in a rhesus monkey during an investigation of the yellow fever virus in the Zika Forest of Uganda; it was also isolated later from humans in Nigeria. The main distribution areas of ZIKV were the African mainland and South-East Asia in the 1980s, Micronesia in 2007, and more recently the Americas in 2014. ZIKV belongs to the Flaviviridae family and Flavivirus genus. ZIKV infection, which is transmitted by Aedes mosquitoes, is an emerging arbovirus disease. The clinical symptoms of ZIKV infection are fever, headache, rashes, arthralgia, and conjunctivitis, which clinically resemble dengue fever syndrome. Sometimes, ZIKV infection has been associated with Guillain-Barré syndrome and microcephaly. At the end of 2015, following an increase in cases of ZIKV infection associated with Guillain-Barré syndrome and microcephaly in newborns in Brazil, the World Health Organization declared a global emergency. Therefore, considering the global distribution and pathogenic nature of this virus, the current study aimed at reviewing the virologic features, transmission patterns, clinical manifestations, diagnosis, treatment, and prevention of ZIKV infection.
Citations
Citations to this article as recorded by
A Review on The Pathogenesis of Cardiovascular Disease of Flaviviridea Viruses Infection Tie-Hua Yang, Wen-Cong Gao, Xin Ma, Qian Liu, Pan-Pan Pang, Yong-Tang Zheng, Yinnong Jia, Chang-Bo Zheng Viruses.2024; 16(3): 365. CrossRef
The race against time: Zika virus on the horizon in Pakistan Moiz Ahmed Khan, Summaiya Zafar Tropical Doctor.2024;[Epub] CrossRef
Zika virus disease: an alarming situation resurfacing on the radar – a short communication Sanobar Shariff, Burhan Kantawala, Nakyanzi Hamiidah, Tularam Yadav, Abubakar Nazir, Olivier Uwishema Annals of Medicine & Surgery.2023; 85(10): 5294. CrossRef